Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.5650 (2.68%) ($5.4100 - $5.8200) on Thu. Jul. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.6% (three month average) | RSI | 81 | Latest Price | $5.5650(2.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 12.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) USO(12%) OIH(11%) XLE(11%) XOP(11%) VFMO(10%) | Factors Impacting BCRX price | BCRX will decline at least -3.8% in a week (0% probabilities). UUP(-10%) TLT(-8%) SHY(-6%) BND(-6%) LQD(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.8% (StdDev 7.6%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.27(5.6%) | 10 Day Moving Average | $5.03(10.64%) | 20 Day Moving Average | $4.64(19.94%) | To recent high | -0.4% | To recent low | 11% | Market Cap | $982m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |